Development and certification of a pharmacopoeial reference standard for primary structure identification of purified recombinant interferon beta-1b by peptide mapping

Medicines based on recombinant human interferons (rhIFNs) beta-1a and beta-1b are used as first-line treatment of multiple sclerosis. Meanwhile, rhIFN beta-1a and beta-1b have structural differences associated with the eukaryotic or prokaryotic expression systems, respectively. Pharmacopoeias requir...

ver descrição completa

Detalhes bibliográficos

Principais autores:	E. O. Goloshchapova, O. B. Rounova, A. S. Minero, O. V. Fadeikina, R. A. Volkova, M. B. Degterev, S. A. Taran, R. R. Shukurov, O. B. Ustinnikova
Formato:	Artigo
Idioma:	Russo
Publicado em:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-04-01
coleção:	Биопрепараты: Профилактика, диагностика, лечение
Assuntos:	recombinant interferon beta-1b identification peptide mapping high performance liquid chromatography mass spectrometry pharmacopoeial reference standard (phrs)
Acesso em linha:	https://www.biopreparations.ru/jour/article/view/415
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!